A study has added to the growing body of evidence that remission of type 2 diabetes may be achieved with aggressive lifestyle changes. DiRECT-Aus set out to determine if a 12-month intervention, incorporating low-energy total diet replacement (TDR), could induce remission in adults with recently diagnosed type 2 diabetes in an Australian primary care setting.
The open-label, single-arm intervention trial recruited adults aged 20–65 years with type 2 diabetes duration of ≤6 years, with HbA1c at entry ≥6.5% (≥48 mmol/mol), BMI >27.0 kg/m2 and who were not treated with insulin. At baseline, there were equal numbers of males and females, with mean age of 52.5 years, weight of 106.9 kg, BMI of 37.7 kg/m2, HbA1c of 7.1% (54 mmol/mol) and type 2 diabetes duration of 2.8 years. Glucose-lowering medications were used by 88%.
Participants (n=155) underwent a 13-week TDR (800–950 kcal, depending on BMI), with fortnightly dietitian visits. This was followed by an 8-week structured food reintroduction and 31 weeks of supported weight management. An increase in daily physical activity was also encouraged, with a target of 15,000 steps.
At 12 months, 86 (56%) of participants had achieved type 2 remission (defined as HbA1c <6.5% [<48 mmol/mol] and off glucose-lowering medications for ≥2 months ± 7 days). The number was highest at the end of the TDR phase at 102 (66%), with 99 (64%) and 92 (90%) at 6 and 9 months, respectively.
Across all of the participants, the mean adjusted weight loss after the TDR was 11.2% (95% CI, 10.3–12.1). At 12 months, it was 8.1% (7.2–9.1). The likelihood of remission was proportional to weight loss, with remission being achieved by 87% of participants who reduced their weight by >15%. The TDR was well tolerated, with only a few serious adverse events that were largely related to hypotension.
Following an intensive lifestyle intervention delivered in primary care, the rate of remission of type 2 diabetes of around one in two participants was similar to the findings of both the DiRECT and DIADEM-I trials, despite being conducted in different countries and across different ethnicities. The investigators conclude that a low-energy TDR is a robust intervention for type 2 diabetes remission, particularly if adopted within 6 years of diagnosis.
The full study findings can be read here.
Journal of
Diabetes Nursing
Issue:
Early View
Type 2 diabetes remission with low-energy diet
A study has added to the growing body of evidence that remission of type 2 diabetes may be achieved with aggressive lifestyle changes. DiRECT-Aus set out to determine if a 12-month intervention, incorporating low-energy total diet replacement (TDR), could induce remission in adults with recently diagnosed type 2 diabetes in an Australian primary care setting.
The open-label, single-arm intervention trial recruited adults aged 20–65 years with type 2 diabetes duration of ≤6 years, with HbA1c at entry ≥6.5% (≥48 mmol/mol), BMI >27.0 kg/m2 and who were not treated with insulin. At baseline, there were equal numbers of males and females, with mean age of 52.5 years, weight of 106.9 kg, BMI of 37.7 kg/m2, HbA1c of 7.1% (54 mmol/mol) and type 2 diabetes duration of 2.8 years. Glucose-lowering medications were used by 88%.
Participants (n=155) underwent a 13-week TDR (800–950 kcal, depending on BMI), with fortnightly dietitian visits. This was followed by an 8-week structured food reintroduction and 31 weeks of supported weight management. An increase in daily physical activity was also encouraged, with a target of 15,000 steps.
At 12 months, 86 (56%) of participants had achieved type 2 remission (defined as HbA1c <6.5% [<48 mmol/mol] and off glucose-lowering medications for ≥2 months ± 7 days). The number was highest at the end of the TDR phase at 102 (66%), with 99 (64%) and 92 (90%) at 6 and 9 months, respectively.
Across all of the participants, the mean adjusted weight loss after the TDR was 11.2% (95% CI, 10.3–12.1). At 12 months, it was 8.1% (7.2–9.1). The likelihood of remission was proportional to weight loss, with remission being achieved by 87% of participants who reduced their weight by >15%. The TDR was well tolerated, with only a few serious adverse events that were largely related to hypotension.
Following an intensive lifestyle intervention delivered in primary care, the rate of remission of type 2 diabetes of around one in two participants was similar to the findings of both the DiRECT and DIADEM-I trials, despite being conducted in different countries and across different ethnicities. The investigators conclude that a low-energy TDR is a robust intervention for type 2 diabetes remission, particularly if adopted within 6 years of diagnosis.
The full study findings can be read here.
Improving care for people experiencing homelessness with diabetes
Prevention of diabetic maculopathy: Trial of oral medication begins
Analysis reveals extent of undiagnosed type 2 diabetes
Assessing self-efficacy among Jordanians with type 1 diabetes
Diabetes prehabilitation programme
Novel antidiabetes drugs improve composite renal outcomes
Standardising a pathway for the first year of care for children and young people diagnosed with type 2 diabetes
Helping homeless adults to overcome the challenges of managing their condition.
16 Apr 2024
Man becomes world’s first recipient of trial drug for diabetic sight loss.
12 Apr 2024
Scale of undiagnosed type 2 diabetes and prediabetes in England revealed in new research.
3 Apr 2024
How belief in ability to perform self-care practices affects healthy behaviours.
3 Apr 2024